ISSN: 1175-5652
Journal Home
Journal Guideline
Applied Health Economics and Health Policy Q1 Unclaimed
Applied Health Economics and Health Policy is a journal indexed in SJR in Medicine (miscellaneous) and Economics and Econometrics with an H index of 56. It has a price of 3190 €. It has an SJR impact factor of 1,291 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,291.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,291
SJR Impact factor56
H Index80
Total Docs (Last Year)225
Total Docs (3 years)4063
Total Refs812
Total Cites (3 years)208
Citable Docs (3 years)3.55
Cites/Doc (2 years)50.79
Ref/DocOther journals with similar parameters
MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1
Compare this journals
Aims and Scope
Best articles by citations
Key Performance Indicators for the Implementation of Social Health Insurance
View moreUntangling the Debate Surrounding Strategies for Achieving Sustainable High Coverage of Insecticide-Treated Nets
View moreAffordability of Medicines and Patients??? Cost-Reducing Behaviour
View moreSelf-Reported Effectiveness of Double-Fine Zones as a Speed Control Measure
View moreRecycling Blood
View moreOpportunities for Use of Blockchain Technology in Medicine
View moreUsing Economic Analyses for Local Priority Setting
View moreA Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance
View moreDo Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?
View moreModelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context
View moreThe Economics of Prevention in a Post-Managed-Care Environment
View moreMedicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US
View morePreferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
View moreSenior Citizens and the Burden of Prescription Drug Outlays
View moreThe Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS
View moreGenetic Health Technology and Economic Evaluation
View moreDisease-Specific Impoverishment Impact of Out-of-Pocket Payments for Health Care: Evidence from Rural Bangladesh
View moreTo Retain or Remove User Fees?
View moreComparing Utility Scores Before and After Hearing-Aid Provision
View moreEQ-5D versus SF-6D in an Older, Chronically Ill Patient Group
View moreMedicare Payment Policy and the Controversy over Hospital Cost Shifting
View moreEconomic Analysis of Thrombo inCode, a Clinical-Genetic Function for Assessing the Risk of Venous Thromboembolism
View moreCommunity-based interventions to promote increased physical activity
View moreOpioid Misuse Among Adolescents: New Evidence from a Misclassification Analysis
View more
Comments